FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a compound of formula (I), which is 5-ethyl-4-methyl-N-[4-[(2S)morpholin-2-yl]phenyl]-1H-pyrazole-3-carboxamide, or to its pharmaceutically acceptable acid addition salt. Invention also relates to a method of producing a compound of formula (I), use thereof, a pharmaceutical composition, a method of activating TAAR.
EFFECT: obtaining a novel compound of formula (I) having TAAR agonist activity.
12 cl, 20 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MORPHOLINE-PYRIDINE DERIVATIVES | 2015 |
|
RU2690154C2 |
| TRIAZOLCARBOXAMIDE DERIVATIVES | 2013 |
|
RU2637938C2 |
| 1-[(4-[BENZOYL(METHYL)AMINO]-3-(PHENYL)BUTYL] AZETIDINE DERIVATIVES FOR TREATMENT OF GASTROINTESTINAL DISORDERS | 2007 |
|
RU2439067C2 |
| HETEROCYCLIC DERIVATIVES AS RECEPTORS ASSOCIATED WITH TRACER AMINES (TAARS) | 2013 |
|
RU2621050C2 |
| 2-OXA-5-AZABICYCLO[2.2.1]HEPTANE-3-YL DERIVATIVES | 2015 |
|
RU2697651C2 |
| PHENYLPYRAZOL DERIVATIVES | 2008 |
|
RU2480456C2 |
| QUINOLINE CARBOXAMIDE AND QUINOLINE CARBONITRILE DERIVATIVES AS mGluR2 NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS AND USE THEREOF | 2012 |
|
RU2610262C2 |
| THERAPEUTIC COMPOUNDS AND COMPOSITIONS AND METHODS OF USING THEM | 2018 |
|
RU2769696C2 |
| CARBOXAMIDE COMPOUNDS AND USE THEREOF AS CALPAIN INHIBITORS | 2010 |
|
RU2567392C2 |
| DERIVATIVES OF 3-SUBSTITUTED 1,5-DIPHENYLPYRAZOLE EFFECTIVE AS CB1 MODULATORS | 2005 |
|
RU2375349C2 |
